{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:00:49Z","timestamp":1775192449613,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:p>\n            Renal dopamine D\n            <jats:sub>1<\/jats:sub>\n            \u2013like receptors (D\n            <jats:sub>1<\/jats:sub>\n            Rs) and angiotensin type 2 receptors (AT\n            <jats:sub>2<\/jats:sub>\n            Rs) are important natriuretic receptors counterbalancing angiotensin type 1 receptor\u2013mediated tubular sodium reabsorption. Here we explore the mechanisms of D\n            <jats:sub>1<\/jats:sub>\n            R and AT\n            <jats:sub>2<\/jats:sub>\n            R interactions in natriuresis. In uninephrectomized, sodium-loaded Sprague-Dawley rats, direct renal interstitial infusion of the highly selective D\n            <jats:sub>1<\/jats:sub>\n            R agonist fenoldopam induced a natriuretic response that was abolished by the AT\n            <jats:sub>2<\/jats:sub>\n            R-specific antagonist PD-123319 or by microtubule polymerization inhibitor nocodazole but not by actin polymerization inhibitor cytochalasin D. By confocal microscopy and immunoelectron microscopy, fenoldopam translocated AT\n            <jats:sub>2<\/jats:sub>\n            Rs from intracellular sites to the apical plasma membranes of renal proximal tubule cells, and this translocation was abolished by nocodazole. Because D\n            <jats:sub>1<\/jats:sub>\n            R activation induces natriuresis via an adenylyl cyclase\/cAMP signaling pathway, we explored whether this pathway is responsible for AT\n            <jats:sub>2<\/jats:sub>\n            R recruitment and AT\n            <jats:sub>2<\/jats:sub>\n            R-mediated natriuresis. Renal interstitial coinfusion of the adenylyl cyclase activator forskolin and 3-isobutly-1-methylxanthine induced natriuresis that was abolished either by PD-123319 or nocodazole but was unaffected by specific the D\n            <jats:sub>1<\/jats:sub>\n            R antagonist SCH-23390. Coadministration of forskolin and 3-isobutly-1-methylxanthine also translocated AT\n            <jats:sub>2<\/jats:sub>\n            Rs to the apical plasma membranes of renal proximal tubule cells; this translocation was abolished by nocodazole but was unaffected by SCH-23390. The results demonstrate that D\n            <jats:sub>1<\/jats:sub>\n            R-induced natriuresis requires AT\n            <jats:sub>2<\/jats:sub>\n            R recruitment to the apical plasma membranes of renal proximal tubule cells in a microtubule-dependent manner involving an adenylyl cyclase\/cAMP signaling pathway. These studies provide novel insights regarding the mechanisms whereby renal D\n            <jats:sub>1<\/jats:sub>\n            Rs and AT\n            <jats:sub>2<\/jats:sub>\n            Rs act in concert to promote sodium excretion in vivo.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.184788","type":"journal-article","created":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T04:37:05Z","timestamp":1325047025000},"page":"437-445","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":50,"title":["Mechanisms of Dopamine D\n            <sub>1<\/sub>\n            and Angiotensin Type 2 Receptor Interaction in Natriuresis"],"prefix":"10.1161","volume":"59","author":[{"given":"Shetal H.","family":"Padia","sequence":"first","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine (S.H.P., B.A.K., N.L.H., S.R.K., R.M.C.) and the Department of Pathology (J.J.G.), University of Virginia Health System, Charlottesville, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon A.","family":"Kemp","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine (S.H.P., B.A.K., N.L.H., S.R.K., R.M.C.) and the Department of Pathology (J.J.G.), University of Virginia Health System, Charlottesville, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Howell","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine (S.H.P., B.A.K., N.L.H., S.R.K., R.M.C.) and the Department of Pathology (J.J.G.), University of Virginia Health System, Charlottesville, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna R.","family":"Keller","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine (S.H.P., B.A.K., N.L.H., S.R.K., R.M.C.) and the Department of Pathology (J.J.G.), University of Virginia Health System, Charlottesville, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Gildea","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine (S.H.P., B.A.K., N.L.H., S.R.K., R.M.C.) and the Department of Pathology (J.J.G.), University of Virginia Health System, Charlottesville, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Carey","sequence":"additional","affiliation":[{"name":"From the Division of Endocrinology and Metabolism, Department of Internal Medicine (S.H.P., B.A.K., N.L.H., S.R.K., R.M.C.) and the Department of Pathology (J.J.G.), University of Virginia Health System, Charlottesville, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.627"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.278.2.F192"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70142-3"},{"key":"e_1_3_3_5_2","first-page":"F247","article-title":"Effects of dopamine blockade on renal sodium excretion","volume":"245","author":"Pelayo JC","year":"1983","unstructured":"Pelayo JC, Fildes RD, Eisner GM, Jose PA. Effects of dopamine blockade on renal sodium excretion. Am J Physiol. 1983;245:F247\u2013F253.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1989.257.3.F469"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57324"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-002-0899-5"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.10.5573"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.13.7271"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201X.2002.00996.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000251881.89610.ee"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000196950.48596.21"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.103036"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.108.124198"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00176774"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000085334.34963.4e"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119531"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90734.2008"},{"key":"e_1_3_3_20_2","first-page":"F711","article-title":"In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition","volume":"276","author":"Zhang Y","year":"1999","unstructured":"Zhang Y, Norian JM, Magyar CE, Holstein-Rathlou NH, Mircheff AK, McDonough AA. In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. Am J Physiol. 1999;276:F711\u2013F719.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00218.2005"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.184788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:19:09Z","timestamp":1715591949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.184788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.184788"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.184788","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"2011-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-11-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}